Thermopylae Holdings Ltd.

Average Profitability
6.49%
Insider Buys Quantity
10
Insider Buys Sum
$20.08M
Insider Sells Quantity
1
Insider Sells Sum
$134.53M

Insider Activity of Thermopylae Holdings Ltd.

According to the SEC Form 4 filings, Thermopylae Holdings Ltd., being in a position of

  1. 10 percent owner at AbCellera Biologics Inc.,
    оver the last 12 months, has bought 283516 shares for $739,977, and sold 0 shares,
    over all time since 2021-06-09, has bought 2761679 shares for $20.08M, and sold 5598420 shares for $134.53M.

The largest purchase of all time was on 2022-05-12 and amounted to 1408468 shares of AbCellera Biologics Inc. for $9.02M.

The largest sale of all time was on 2021-06-09 and amounted to 5598420 shares of AbCellera Biologics Inc. for $134.53M.

Biography of Thermopylae Holdings Ltd.

No biography is available at this moment.

2024-08-29PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
283,516
0.0993%
$2.61$739,977+4.35%
2023-05-26PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
153,000
0.051%
$6.52$997,728-26.32%
2022-12-16PurchaseAbCellera Biologics Inc.
ABCL
director
85,102
0.0295%
$10.10$859,249-33.5%
2022-08-19PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
200,000
0.0702%
$11.46$2.29M-19.58%
2022-06-14PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
9,173
0.0029%
$8.05$73,842+16.48%
2022-06-13PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
54,915
0.0189%
$8.03$441,066+25%
2022-06-06PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
64,545
0.0222%
$7.50$483,965+33.64%
2022-05-13PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
300,000
0.1057%
$7.26$2.18M+41.77%
2022-05-12PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
1.41M
0.4723%
$6.41$9.02M+52.76%
2021-11-11PurchaseAbCellera Biologics Inc.
ABCL
10 percent owner
202,960
0.0722%
$14.76$3M-31.79%
2021-06-09SaleAbCellera Biologics Inc.
ABCL
10 percent owner
5.6M
2.0732%
$24.03$134.53M-39.43%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.